| Community Foot Clinic | |
|
904 E Plaza Street, Albert Lea, MN 56007 | |
| (507) 373-6133 | |
| (507) 373-0261 |
| Full Name | Community Foot Clinic |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 904 E Plaza Street, Albert Lea, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215149364 | NPI | - | NPPES |
| 803725600 | Medicaid | MN | |
| 0491043 | Medicaid | IA | |
| 236266000 | Medicaid | MN | |
| 0953471 | Medicaid | IA | |
| 480027955 | Other | MN | MEDICARE RAILROAD |
| CS1038 | Other | MN | MEDICARE RAILROAD |
| P00309735 | Other | MN | MEDICARE RAILROAD |
| 213825500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Primary |
| Provider Name | Travis D Klatt |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1104223635 PECOS PAC ID: 9436409729 Enrollment ID: I20180907000237 |
News Archive
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
One traditional approach to pharmaceutical design uses so-called "first messengers" – hormones, other natural facilitators or synthetic products – to initiate various cellular cascades for the desired physiological effect. To date, despite concerted efforts at all levels of research, this approach has failed to develop a truly successful obesity drug to address this major global health problem.
Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year in a randomized trial, results that suggest self-monitoring should not be routine in these patients, according to a new study published by JAMA Internal Medicine.
Acuity, Incorporated, a fabless provider of stable high-performance MEMS pressure sensors, is now shipping the AC3050-010 very stable low pressure sensor die with a 10mbar full-scale rating. Expanding the low-pressure end of Acuity's piezoresistive pressure sensor product offerings to 10 mbar full-scale, the AC3050-010 complements the existing AC3030 series 20 to 100 mbar full-scale MEMS pressure sensor family. The AC3050-010 is targeted at low-pressure instrumentation in industrial measurement, medical and HVAC applications.
Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
› Verified 4 days ago
| Provider Name | Abigail M Smith |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1366853715 PECOS PAC ID: 3971724071 Enrollment ID: I20210903002794 |
News Archive
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
One traditional approach to pharmaceutical design uses so-called "first messengers" – hormones, other natural facilitators or synthetic products – to initiate various cellular cascades for the desired physiological effect. To date, despite concerted efforts at all levels of research, this approach has failed to develop a truly successful obesity drug to address this major global health problem.
Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year in a randomized trial, results that suggest self-monitoring should not be routine in these patients, according to a new study published by JAMA Internal Medicine.
Acuity, Incorporated, a fabless provider of stable high-performance MEMS pressure sensors, is now shipping the AC3050-010 very stable low pressure sensor die with a 10mbar full-scale rating. Expanding the low-pressure end of Acuity's piezoresistive pressure sensor product offerings to 10 mbar full-scale, the AC3050-010 complements the existing AC3030 series 20 to 100 mbar full-scale MEMS pressure sensor family. The AC3050-010 is targeted at low-pressure instrumentation in industrial measurement, medical and HVAC applications.
Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Community Foot Clinic 904 E Plaza Street, Albert Lea, MN 56007 Ph: (507) 373-6133 | Community Foot Clinic 904 E Plaza Street, Albert Lea, MN 56007 Ph: (507) 373-6133 |
News Archive
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
One traditional approach to pharmaceutical design uses so-called "first messengers" – hormones, other natural facilitators or synthetic products – to initiate various cellular cascades for the desired physiological effect. To date, despite concerted efforts at all levels of research, this approach has failed to develop a truly successful obesity drug to address this major global health problem.
Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year in a randomized trial, results that suggest self-monitoring should not be routine in these patients, according to a new study published by JAMA Internal Medicine.
Acuity, Incorporated, a fabless provider of stable high-performance MEMS pressure sensors, is now shipping the AC3050-010 very stable low pressure sensor die with a 10mbar full-scale rating. Expanding the low-pressure end of Acuity's piezoresistive pressure sensor product offerings to 10 mbar full-scale, the AC3050-010 complements the existing AC3030 series 20 to 100 mbar full-scale MEMS pressure sensor family. The AC3050-010 is targeted at low-pressure instrumentation in industrial measurement, medical and HVAC applications.
Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
› Verified 4 days ago
Travis Klatt, Podiatrist Medicare: Medicare Enrolled Practice Location: 904 E Plaza St, Albert Lea, MN 56007 Phone: 507-373-6133 Fax: 507-373-0261 | |
Dr. Nathan D Sanders, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 404 West Fountain Street, Albert Lea, MN 56007 Phone: 952-239-6313 |